BCI
OM icon

Brinker Capital Investments’s Outset Medical OM Stock Holding History

Brinker Capital Investments’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-744
Closed -$60.1K – 1731
2023
Q4 		$60.1K Sell
744
-480
-39% -$39.1K ﹤0.01% 1630
2023
Q3 		$200K Sell
1,224
-62
-5% -$14.6K ﹤0.01% 1552
2023
Q2 		$422K Sell
1,286
-20
-2% -$6.1K ﹤0.01% 1273
2023
Q1 		$360K Buy
1,306
+5
+0.4% +$1.83K ﹤0.01% 1274
2022
Q4 		$504K Sell
1,301
-23
-2% -$6.49K 0.01% 976
2022
Q3 		$316K Buy
1,324
+263
+25% +$70.4K 0.01% 1096
2022
Q2 		$237K Sell
1,061
-25
-2% -$10.8K ﹤0.01% 1249
2022
Q1 		$740K Sell
1,086
-207
-16% -$125K 0.01% 902
2021
Q4 		$894K Buy
+1,293
New +$956K 0.01% 859

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Brinker Capital Investments's OM Position: Q1 2024 in Review

Brinker Capital Investments sold out of Outset Medical (OM) in Q1 2024, closing a stake of 744 shares — an estimated $60.1K sold.

Brinker Capital Investments first reported a position in OM in Q4 2021 and held it in 9 quarters. The position peaked at $894K in Q4 2021. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

  • Brinker Capital Investments reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
  • Brinker Capital Investments sold 744 Outset Medical shares in Q1 2024, an estimated $60.1K.
  • Brinker Capital Investments first reported a position in Outset Medical in Q4 2021 and held it in 9 quarters.
  • Brinker Capital Investments's Outset Medical position peaked at $894K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Brinker Capital Investments's 13F filing for Q1 2024, filed 31 Jul 2025.